Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Topper James N
Relationship:  
City:   Seattle
State:   WA
   
Insider Summary:
  
   
Companies Owned :   14    
Direct Shares   20,715,944    

Indirect Shares

  33,777,420      
Direct Value   $195,395,319    

Indirect Value

  $517,185,955      
Total Shares   54,493,364      
Total Value   $712,581,273      


Anaptysbio Inc
 $1,911,204 Alpine Immune Sciences Inc
 $96,422,952 Mirum Pharmaceuticals, Inc.
 $0 Arcutis Biotherapeutics, Inc.
 $91,300,561 Passage Bio, Inc.
 $5,760,602 Phathom Pharmaceuticals, Inc.
 $0 Anaptysbio Inc
 $1,911,204 Alpine Immune Sciences Inc
 $96,422,952 Mirum Pharmaceuticals, Inc.
 $0 Arcutis Biotherapeutics, Inc.
 $91,300,561 Passage Bio, Inc.
 $5,760,602 Phathom Pharmaceuticals, Inc.
 $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    3   
    1    

     Stock price went up :

    0   
    1    
     Stock price went down :
    3   
    0    
   
     Gain/Loss Ratio :
   -3.0   
   1.0   
     Percentage Gain/Loss :
   -17.1%
 0.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            La Jolla Pharmaceutical Co LJPC Director 2005-12-14 0 2009-02-26 0    Premium*  
            Amicus Therapeutics Inc FOLD Director, 10% Owner 2007-06-05 0 2008-03-10 3,520,678    Premium*  
            Portola Pharmaceuticals Inc PTLA Director 2013-05-28 0 2013-05-28 1,428,954    Premium*  
            Sierra Oncology Inc SRRA Director, 10% Owner 2015-07-21 0 2017-02-14 8,112,121    Premium*  
            Anaptysbio Inc ANAB Director 2020-11-16 80,812 2020-11-16 199,529    Premium*  
            Alpine Immune Sciences Inc ALPN Director 2022-02-11 1,484,115 2024-05-18 0    Premium*  
            Allena Pharmaceuticals, Inc. ALNA Director, 10% Owner 2017-11-06 0 2017-11-06 3,330,373    Premium*  
            Aptinyx Inc. APTX Director 2018-06-25 0 2020-03-31 3,195,055    Premium*  
            Entasis Therapeutics Holdings Inc. ETTX Director, 10% Owner 2018-09-28 0 2018-09-28 1,349,953    Premium*  
            Mirum Pharmaceuticals, Inc. MIRM 10% Owner 2019-07-22 3,566,912 2019-07-22 0    Premium*  
            Arcutis Biotherapeutics, Inc. ARQT 10% Owner 2020-02-04 10,542,790 0    Premium*  
            Passage Bio, Inc. PASG 10% Owner 2020-03-03 5,009,219 2020-03-03 0    Premium*  
            Phathom Pharmaceuticals, Inc. PHAT 2024-05-23 32,096 2024-05-23 5,831,328    Premium*  
            Newamsterdam Pharma Ord Shs NAMS 0 2024-03-26 6,809,429    Premium*  
* Premium Members only  

Records found :    95         Free Registration Required For Full Results.    Limit: 25

Download
  Page 3 of 4
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
FOLD Amicus Therapeutics Inc Director   –       •       •   2008-02-25 4 B $9.45 $93,680 I/I 9,700 719,681 2.25 -
FOLD Amicus Therapeutics Inc Director   –       •       •   2008-02-12 4 B $9.99 $94,213 I/I 9,400 617,667 2.25 -
FOLD Amicus Therapeutics Inc Director   –       •       •   2008-02-19 4 B $9.74 $95,015 I/I 9,600 646,167 2.25 -
FOLD Amicus Therapeutics Inc Director   –       •       •   2008-03-05 4 B $9.64 $116,133 I/I 12,008 855,026 2.25 -
LJPC La Jolla Pharmaceutical C... Director   –       •      –    2009-02-24 4 S $0.07 $120,827 I/I (1,662,000) 4,210,711 0 -
FOLD Amicus Therapeutics Inc Director   –       •       •   2008-02-01 4 B $9.75 $133,207 I/I 13,600 370,315 2.25 -
FOLD Amicus Therapeutics Inc Director   –       •       •   2008-02-27 4 B $9.65 $143,616 I/I 14,700 742,381 2.25 -
LJPC La Jolla Pharmaceutical C... Director   –       •      –    2009-02-26 4 S $0.06 $154,927 I/I (2,756,711) 0 0 -
FOLD Amicus Therapeutics Inc Director   –       •       •   2007-06-29 4 B $11.41 $159,538 I/I 13,900 167,315 2.25 -
NAMS Newamsterdam Pharma Ord S...   –       •      –    2024-03-26 4 B $21.50 $181,224 I/I 8,429 3,008,429 0.01 -
FOLD Amicus Therapeutics Inc Director   –       •       •   2007-07-27 4 B $11.26 $202,951 I/I 17,800 222,815 2.25 -
FOLD Amicus Therapeutics Inc Director   –       •       •   2008-03-06 4 B $9.90 $221,723 I/I 22,146 915,164 2.25 -
FOLD Amicus Therapeutics Inc Director   –       •       •   2008-01-31 4 B $9.81 $227,815 I/I 22,885 281,515 2.25 -
FOLD Amicus Therapeutics Inc Director   –       •       •   2008-02-07 4 B $9.96 $255,759 I/I 25,400 568,767 2.25 -
FOLD Amicus Therapeutics Inc Director   –       •       •   2008-02-04 4 B $9.92 $258,380 I/I 25,352 395,667 2.25 -
FOLD Amicus Therapeutics Inc Director   –       •       •   2008-02-01 4 B $9.45 $274,739 I/I 28,700 356,715 2.25 -
FOLD Amicus Therapeutics Inc Director   –       •       •   2008-02-01 4 B $9.09 $296,107 I/I 32,100 328,015 2.25 -
FOLD Amicus Therapeutics Inc Director   –       •       •   2008-02-08 4 B $9.94 $340,318 I/I 33,800 602,567 2.25 -
FOLD Amicus Therapeutics Inc Director   –       •       •   2007-08-08 4 B $11.50 $340,400 I/I 29,600 252,415 2.25 -
FOLD Amicus Therapeutics Inc Director   –       •       •   2007-07-25 4 B $11.35 $341,342 I/I 29,700 197,015 2.25 -
FOLD Amicus Therapeutics Inc Director   –       •       •   2008-02-05 4 B $10.32 $344,160 I/I 32,864 497,890 2.25 -
FOLD Amicus Therapeutics Inc Director   –       •       •   2008-02-04 4 B $10.32 $354,429 I/I 33,823 429,490 2.25 -
FOLD Amicus Therapeutics Inc Director   –       •       •   2008-02-05 4 B $10.16 $363,027 I/I 35,536 465,026 2.25 -
FOLD Amicus Therapeutics Inc Director   –       •       •   2008-03-05 4 B $9.76 $371,681 I/I 37,992 893,018 2.25 -
FOLD Amicus Therapeutics Inc Director   –       •       •   2008-03-03 4 B $9.51 $422,230 I/I 43,674 811,092 2.25 -

  95  Records found
  1   2   3  4      
  Page 3 of 4  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed